The Guzman y Gomez ASX IPO gained over 35% on its first trading day – but will the hot run last?
The Guzman y Gomez ASX IPO was a spectacular success. After months of rumours, and a few weeks marketing (and…
Share buybacks: Are they a good sign or a waste of money?
Share buybacks are a controversial topic amongst investors. Some say it is a waste of money, others will welcome it…
AFT Pharmaceuticals (ASX:AFP): A gem of a dual-listed healthcare company
AFT Pharmaceuticals (ASX:AFP) may not spring to mind as the best company to have come out of New Zealand. Many…
Can Tabcorp’s nеw boss improve the stock’s dwindling odds?
Tabcorp (ASX: TAH) has had a dog of a year, with its share price dropping roughly 40% in the last…
The dream of Bitcoin ETFs on the ASX will soon become a reality, but here’s what investors need to know
For a long time, the concept of bitcoin ETFs has been little more than a pipedream, until the SEC finally…
Should I buy Apple shares from Australia? Can the US$3.3tn behemoth grow any further?
Investors asking themselves, ‘Should I buy Apple shares from Australia,’ are not just considering buying shares any company, but the…
The ASX CHESS Replacement: Will the excruciating wait finally be over by the end of the 2020s?
The long-promised ASX CHESS replacement has been a saga that likely has more twists and turns to come. Despite prior…
AI Wars: Which Tech Giant’s Artificial Intelligence is better?
Artificial Intelligence (AI) is no longer just a futuristic concept—it’s here, transforming our daily lives from the way we commute…
Highest yielding ASX dividend stocks: Here are 5 to take a look at!
The list of highest yielding ASX dividend stocks fluctuates substantially from year to year, and even from month to month.…
When will Canva list? Here’s why investors’ patience may pay off in the next 2 years
When will Canva list? This has been a hot question for several years now. The latest answer seems to be…
How to minimise the risks of biotech shares on the ASX? Here are 4 traits investors should look for
To minimise the risks of biotech shares is a major challenge for investors, but not one that is insurmountable. The…
Superior Resources (ASX:SPQ) goes hunting in north Queensland ‘elephant country’
You’ve got to hand it to Superior Resources (ASX: SPQ) for ambition. Some time ago this Brisbane-based explorer started pursuing…
Here’s what is the Price to Earnings Ratio (P/E Ratio) and 4 key ways investors can use it to their advantage!
What is the Price to Earnings Ratio or the P/E ratio? The P/E ratio is the most used multiple of…
Meme stocks: Are they still something investors should care about in 2024?
Meme stocks have become a popular topic in recent years, especially within the investing community. We thought we’d take a…
The case for Australian interest rates to come down faster than people are expecting
Australian interest rates influenced by US inflation trend On 13 June, US consumer prices (CPI) came in lower than expected…